AVENUE THERAPEUTICS, INC.

For the period ended Dec 31, 2024. Filed Mar 31, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 31, 2025

ATXI$0.42-50.7%Stored close · as of Mar 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands, except share and per share amounts)

	December 31,	December 31,
	2024	2023
ASSETS
Current assets:
Cash and cash equivalents	$2,594	$1,783
Prepaid expenses and other current assets	78	67
Total assets	$2,672	$1,850
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses	$654	$287
Accounts payable and accrued expenses - related party	146	323
Warrant liability	16	586
Total current liabilities	816	1,196
Total liabilities	816	1,196
Commitments and Contingencies (Note 6)
Stockholders’ equity
Preferred stock ($0.0001 par value), 2,000,000 shares authorized
Class A Preferred stock, 250,000 shares issued and outstanding as of December 31, 2024 and 2023, respectively	—	—
Common stock ($0.0001 par value)
Common shares, 200,000,000 shares authorized and 2,108,670 shares issued and outstanding as of December 31, 2024; and 75,000,000 shares authorized and 341,324 shares issued and outstanding as of December 31, 2023	—	3
Additional paid-in capital	105,377	92,507
Accumulated deficit	(102,580)	(90,928)
Total stockholders’ equity attributed to the Company	2,797	1,582
Non-controlling interests	(941)	(928)
Total stockholders’ equity	1,856	654
Total liabilities and stockholders’ equity	$2,672	$1,850

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.